NCT03899519 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Gupta D, Srirajakalidindi A, Ittiara B, Apple L, Toshniwal G, Haber H
Ultrasonographic modification of Cormack Lehane classification for pre-anesthetic airway assessment. Middle East J Anaesthesiol. 2012 Oct;21(6):835-42.
Rana S, Verma V, Bhandari S, Sharma S, Koundal V, Chaudhary SK
Point-of-care ultrasound in the airway assessment: A correlation of ultrasonography-guided parameters to the Cormack-Lehane Classification. Saudi J Anaesth. 2018 Apr-Jun;12(2):292-296. doi: 1
Soltani Mohammadi S, Saliminia A, Nejatifard N, Azma R
Usefulness of Ultrasound View of Larynx in Pre-Anesthetic Airway Assessment: A Comparison With Cormack-Lehane Classification During Direct Laryngoscopy. Anesth Pain Med. 2016 Aug 15;6(6):e39566. doi:

The Correlations of the Findings Obtained From Airway Ultrasonography With Cormack Lehane Classification in Patients With Obstructive Sleep Apnoea - A Cross Sectional Study

Details for clinical trial NCT03899519

Clinical trial NCT03899519 - References